Report this content as offensive or unsuitable

Tell us about this content

Important, please read before continuing

This form should only be used for serious complaints about comments posted to the Page Comments section that break the NHS Choices Moderation Rules. This would include, but is not limited to harassing, abusive, threatening, libelous, or otherwise objectionable material.

The comment about which you complain will be sent to a moderator, who will decide whether it breaks the NHS Choices Moderation Rules. You will be contacted in due course once a decision has been made.

We need your email address so we can keep you updated about the status of your complaint.

Return to this content

Original content

Robert Mathie said on 03 July 2009

Readers are advised to consult the websites of the British Homeopathic Association and the Faculty of Homeopathy (links are top right of this page) for a precise account of homeopathy and its context within the NHS. From these sites it will be clear, for example, that 44% of randomised controlled trials in homeopathy have reported positive effects, and only 7% have been negative. These data are similar to the findings of a comprehensive meta-analysis of placebo-controlled trials of homeopathy (Linde et al., Lancet 1997; vol 350: pp834–43), in which 48% of trials were positive. It should also be noted that different homeopathic remedies and different dilutions of the same remedy have been distinguished from each other using Raman and infrared spectroscopy, even though all should theoretically contain nothing but water (Rao et al., Homeopathy 2007; vol 96: pp175–182). Such findings may relate to complex processes such as the formation, during succussion, of colloidal nanobubbles that could contain the remedy source material. The cost of homeopathy to the National Health Service is minuscule. Recent figures show that the NHS spent £12 million on homeopathy over a three-year period from 2005. £4 million a year for homeopathy (equating to 6 pence per annum per head of the British population) compares more than favourably to the amount the NHS spends each year on management consultants for example (approx. £320 million) or on treating in-patients with adverse reactions to conventional drugs (approx. £460 million). Robert Mathie PhD Research Development Adviser British Homeopathic Association